🎁 Black Friday: up to 50% off of annual plans
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
121.40
-2.62 (-2.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Protagonist Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,9245,4602,3001,3235371,632
Market Cap Growth
48.89%137.35%73.94%146.40%-67.12%88.22%
Enterprise Value
7,0984,7921,7281,0022741,286
Last Close Price
121.4087.3438.6022.9310.9134.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
24.64-8.36---
Forward PE
94.1559.7636.33---
PS Ratio
14.36118.665.3022.0420.1959.67
PB Ratio
7.308.883.413.932.495.44
P/TBV Ratio
7.308.883.413.932.495.44
P/FCF Ratio
72.6097.3612.59---
P/OCF Ratio
72.0994.6812.49---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.87104.143.9816.6910.2947.01
EV/EBITDA Ratio
21.86-6.81---
EV/EBIT Ratio
21.97-6.84---
EV/FCF Ratio
65.0385.459.45---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.020.020.000.020.02
Debt / EBITDA Ratio
0.03-0.04---
Debt / FCF Ratio
0.080.180.06---
Net Debt / Equity Ratio
-0.76-1.03-0.81-1.01-1.08-1.07
Net Debt / EBITDA Ratio
-2.544.05-2.163.671.792.57
Net Debt / FCF Ratio
-7.57-11.33-3.004.812.152.95
Asset Turnover
0.600.070.790.200.090.08
Quick Ratio
19.7612.5912.3916.547.617.55
Current Ratio
19.8512.7112.4816.717.807.74
Return on Equity (ROE)
39.56%-20.18%54.39%-28.59%-49.41%-43.32%
Return on Assets (ROA)
37.04%-18.42%49.91%-26.06%-42.78%-37.36%
Return on Invested Capital (ROIC)
169.04%-97.34%82.47%-33.84%-50.49%-42.81%
Return on Capital Employed (ROCE)
29.60%-25.40%36.30%-27.80%-60.60%-41.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4.06%-2.38%11.96%-5.97%-23.73%-7.69%
FCF Yield
1.38%1.03%7.95%-5.36%-20.29%-6.68%
Buyback Yield / Dilution
-8.19%2.31%-14.65%-15.74%-5.87%-34.67%
SEC Filings: 10-K · 10-Q